PURPOSE: At present, the only approved fluorescent tracer for clinical near-infrared fluorescence-guided sentinel node (SN) detection is indocyanine green (ICG), but the use of this tracer is limited due to its poor retention in the SN resulting in the detection of higher tier nodes. We describe the development and characterization of a next-generation fluorescent tracer, nanocolloidal albumin-IRDye 800CW that has optimal properties for clinical SN detection. METHODS: The fluorescent dye IRDye 800CW was covalently coupled to colloidal human serum albumin (HSA) particles present in the labelling kit Nanocoll in a manner compliant with current Good Manufacturing Practice. Characterization of nanocolloidal albumin-IRDye 800CW included determination of conjugation efficiency, purity, stability and particle size. Quantum yield was determined in serum and compared to that of ICG. For in vivo evaluation a lymphogenic metastatic tumour model in rabbits was used. Fluorescence imaging was performed directly after peritumoral injection of nanocolloidal albumin-IRDye 800CW or the reference ICG/HSA (i.e. ICG mixed with HSA), and was repeated after 24 h, after which fluorescent lymph nodes were excised. RESULTS: Conjugation of IRDye 800CW to nanocolloidal albumin was always about 50% efficient and resulted in a stable and pure product without affecting the particle size of the nanocolloidal albumin. The quantum yield of nanocolloidal albumin-IRDye 800CW was similar to that of ICG. In vivo evaluation revealed noninvasive detection of the SN within 5 min of injection of either nanocolloidal albumin-IRDye 800CW or ICG/HSA. No decrease in the fluorescence signal from SN was observed 24 h after injection of the nanocolloidal albumin-IRDye 800CW, while a strong decrease or complete disappearance of the fluorescence signal was seen 24 h after injection of ICG/HSA. Fluorescence-guided SN biopsy was very easy. CONCLUSION: Nanocolloidal albumin-IRDye 800CW is a promising fluorescent tracer with optimal kinetic features for SN detection.
PURPOSE: At present, the only approved fluorescent tracer for clinical near-infrared fluorescence-guided sentinel node (SN) detection is indocyanine green (ICG), but the use of this tracer is limited due to its poor retention in the SN resulting in the detection of higher tier nodes. We describe the development and characterization of a next-generation fluorescent tracer, nanocolloidal albumin-IRDye800CW that has optimal properties for clinical SN detection. METHODS: The fluorescent dye IRDye800CW was covalently coupled to colloidal humanserum albumin (HSA) particles present in the labelling kit Nanocoll in a manner compliant with current Good Manufacturing Practice. Characterization of nanocolloidal albumin-IRDye800CW included determination of conjugation efficiency, purity, stability and particle size. Quantum yield was determined in serum and compared to that of ICG. For in vivo evaluation a lymphogenic metastatic tumour model in rabbits was used. Fluorescence imaging was performed directly after peritumoral injection of nanocolloidal albumin-IRDye800CW or the reference ICG/HSA (i.e. ICG mixed with HSA), and was repeated after 24 h, after which fluorescent lymph nodes were excised. RESULTS: Conjugation of IRDye800CW to nanocolloidal albumin was always about 50% efficient and resulted in a stable and pure product without affecting the particle size of the nanocolloidal albumin. The quantum yield of nanocolloidal albumin-IRDye800CW was similar to that of ICG. In vivo evaluation revealed noninvasive detection of the SN within 5 min of injection of either nanocolloidal albumin-IRDye800CW or ICG/HSA. No decrease in the fluorescence signal from SN was observed 24 h after injection of the nanocolloidal albumin-IRDye800CW, while a strong decrease or complete disappearance of the fluorescence signal was seen 24 h after injection of ICG/HSA. Fluorescence-guided SN biopsy was very easy. CONCLUSION: Nanocolloidal albumin-IRDye800CW is a promising fluorescent tracer with optimal kinetic features for SN detection.
Authors: Anne C van Leeuwen; Tessa Buckle; Gavin Bendle; Lenka Vermeeren; Renato Valdés Olmos; Henk G van de Poel; Fijs W B van Leeuwen Journal: J Biomed Opt Date: 2011 Jan-Feb Impact factor: 3.170
Authors: Christoph Hirche; Dawid Murawa; Zarah Mohr; Soeren Kneif; Michael Hünerbein Journal: Breast Cancer Res Treat Date: 2010-02-07 Impact factor: 4.872
Authors: Henk G van der Poel; Tessa Buckle; Oscar R Brouwer; Renato A Valdés Olmos; Fijs W B van Leeuwen Journal: Eur Urol Date: 2011-04-01 Impact factor: 20.096
Authors: Gary L Ross; David S Soutar; D Gordon MacDonald; Taimur Shoaib; Ivan Camilleri; Andrew G Roberton; Jens A Sorensen; Jorn Thomsen; Peter Grupe; Julio Alvarez; L Barbier; J Santamaria; Tito Poli; Olindo Massarelli; Enrico Sesenna; Adorján F Kovács; Frank Grünwald; Luigi Barzan; Sandro Sulfaro; Franco Alberti Journal: Ann Surg Oncol Date: 2004-06-14 Impact factor: 5.344
Authors: Susan L Troyan; Vida Kianzad; Summer L Gibbs-Strauss; Sylvain Gioux; Aya Matsui; Rafiou Oketokoun; Long Ngo; Ali Khamene; Fred Azar; John V Frangioni Journal: Ann Surg Oncol Date: 2009-07-07 Impact factor: 5.344
Authors: Henk G van der Poel; Alfons J M Balm; Omgo E Nieweg; Renato A Valdés Olmos Journal: Eur J Nucl Med Mol Imaging Date: 2012-04-24 Impact factor: 9.236
Authors: Christina Bluemel; Domenico Rubello; Patrick M Colletti; Remco de Bree; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2015-04-28 Impact factor: 9.236
Authors: Daniel L J Thorek; David Ulmert; Ndeye-Fatou M Diop; Mihaela E Lupu; Michael G Doran; Ruimin Huang; Diane S Abou; Steven M Larson; Jan Grimm Journal: Nat Commun Date: 2014 Impact factor: 14.919
Authors: Joost R van der Vorst; Boudewijn E Schaafsma; Floris P R Verbeek; Stijn Keereweer; Jeroen C Jansen; Lilly-Ann van der Velden; Antonius P M Langeveld; Merlijn Hutteman; Clemens W G M Löwik; Cornelis J H van de Velde; John V Frangioni; Alexander L Vahrmeijer Journal: Oral Oncol Date: 2012-08-28 Impact factor: 5.337
Authors: Boudewijn E Schaafsma; Floris P R Verbeek; Joost R van der Vorst; Merlijn Hutteman; Peter J K Kuppen; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer Journal: J Surg Res Date: 2013-01-25 Impact factor: 2.192
Authors: Jens Osterkamp; Rune B Strandby; Nikolaj Nerup; Morten Bo Søndergaard Svendsen; Lars Bo Svendsen; Michael Patrick Achiam Journal: Langenbecks Arch Surg Date: 2021-07-10 Impact factor: 3.445